Benzoxanthone Derivatives as Emerging Therapeutic Agents: A Comprehensive Review.

IF 4 3区 医学 Q2 CHEMISTRY, MEDICINAL
Jon Jyoti Sahariah, Aparoop Das, Kalyani Pathak, Urvashee Gogoi, Manisha Sahariah, Saptasikha Gogoi
{"title":"Benzoxanthone Derivatives as Emerging Therapeutic Agents: A Comprehensive Review.","authors":"Jon Jyoti Sahariah, Aparoop Das, Kalyani Pathak, Urvashee Gogoi, Manisha Sahariah, Saptasikha Gogoi","doi":"10.2174/0113895575491607260828102537","DOIUrl":null,"url":null,"abstract":"<p><p>Benzoxanthone derivatives represent an important subclass of xanthone-based heterocyclic compounds that have attracted increasing scientific attention due to their diverse structural features and wide range of reported biological activities. This review compiles and critically summarizes published literature on the sources, chemical synthesis, structural modifications, and pharmacological properties of benzoxanthone derivatives. Emphasis is placed on documented structureactivity relationships, highlighting the influence of ring fusion, substituent pattern, and extended π- conjugation on biological responses. Reported experimental findings from in silico, in vitro, and in vivo studies demonstrating anticancer, antimicrobial, antioxidant, anti-inflammatory, and enzyme inhibitory activities are discussed based on available evidence. The review also outlines current synthetic strategies and analytical approaches used to characterize benzoxanthone compounds, along with reported limitations in solubility, bioavailability, and toxicity assessment. By presenting consolidated factual information from existing studies, this article aims to provide a comprehensive reference for researchers and to support further systematic investigation of benzoxanthone derivatives in medicinal and pharmaceutical research.</p>","PeriodicalId":18548,"journal":{"name":"Mini reviews in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mini reviews in medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113895575491607260828102537","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Benzoxanthone derivatives represent an important subclass of xanthone-based heterocyclic compounds that have attracted increasing scientific attention due to their diverse structural features and wide range of reported biological activities. This review compiles and critically summarizes published literature on the sources, chemical synthesis, structural modifications, and pharmacological properties of benzoxanthone derivatives. Emphasis is placed on documented structureactivity relationships, highlighting the influence of ring fusion, substituent pattern, and extended π- conjugation on biological responses. Reported experimental findings from in silico, in vitro, and in vivo studies demonstrating anticancer, antimicrobial, antioxidant, anti-inflammatory, and enzyme inhibitory activities are discussed based on available evidence. The review also outlines current synthetic strategies and analytical approaches used to characterize benzoxanthone compounds, along with reported limitations in solubility, bioavailability, and toxicity assessment. By presenting consolidated factual information from existing studies, this article aims to provide a comprehensive reference for researchers and to support further systematic investigation of benzoxanthone derivatives in medicinal and pharmaceutical research.

苯并恶蒽酮衍生物作为新兴的治疗剂:综述。
苯并杂蒽酮衍生物是一类重要的杂环类杂蒽酮类化合物,由于其多样的结构特征和广泛的生物活性而受到越来越多的科学关注。本文对苯并恶蒽酮衍生物的来源、化学合成、结构修饰和药理性质等方面的文献进行了综述。重点放在已记录的构效关系上,强调环融合、取代基模式和扩展π共轭对生物反应的影响。在现有证据的基础上,讨论了硅、体外和体内研究中显示的抗癌、抗菌、抗氧化、抗炎和酶抑制活性的实验结果。该综述还概述了目前用于表征苯并恶蒽酮化合物的合成策略和分析方法,以及在溶解度、生物利用度和毒性评估方面的局限性。通过对现有研究的综合事实信息,本文旨在为研究人员提供全面的参考,并支持对苯并恶蒽酮衍生物在医学和制药研究中的进一步系统研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
0.00%
发文量
231
审稿时长
6 months
期刊介绍: The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines. Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies. Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书